Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-24-010858

CVP, JAPAC sold 2,500 shares at $74.08 ($185,196)

  • CVP, JAPAC acquired 2,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lippis Daniel J. · CVP, JAPAC

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-12-16 Exercise or conversion : show line 1 in the form 10b5-1 +2,500 $45.28 $113,192 25,689.07 D
2024-12-16 Sale : show line 2 in the form 10b5-1 −2,500 $74.08 $185,196 23,189.07 D
Open-market sales · 2,500 sh · avg $74.08 · $185,196

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-12-16 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −2,500 2,030 D
Loading xslF345X05/doc4.xml…